XOMAP Q1 2021 Earnings — XOMA Corporation Revenue & Financial Results | Market Cap Arena

XOMAPXOMA Corporation

$311M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$375,000-53.4% YoY

Gross Profit

$314,00083.7% margin

Operating Income

-$6M-1713.9% margin

Net Income

-$7M-1966.1% margin

EPS (Diluted)

$-0.65

QoQ Revenue Growth

-98.6%

Cash Flow

Operating Cash Flow

-$914,000

Free Cash Flow

-$14M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$120M

Total Liabilities

$38M

Stockholders' Equity

$82M

Cash & Equivalents

$68M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$375,000	$804,000	-53.4%
Gross Profit	$314,000	$742,000	-57.7%
Operating Income	-$6M	-$6M	-14.4%
Net Income	-$7M	-$5M	-55.0%